Objective: There have been con¯icts concerning the criteria for diagnosing malignant epithelial neoplasms of thymic origin. To differentiate thymic carcinomas from thymomas, the maturation stage of T-lineage lymphoid cells in®ltrating thymomas and thymic carcinomas was examined by¯ow cytometry to associate it with the degree of tumor malignancy. Methods: Multidimensional¯ow cytometric analysis was performed on the lymphoid cells extracted from 27 thymic epithelial neoplasms (14 encapsulated thymomas, ten invasive thymomas, and three thymic carcinomas) by using anti-CD3, -CD4, -CD8, -CD10, -CD20, -CD38, -CD45RA, and -CD45RO monoclonal antibodies. Results: CD4 and CD8 were co-expressed on 76.8% of the lymphoid cells in encapsulated thymoma (N 14), 59.2% in invasive thymoma (N 10), and 6.7% in thymic cancer (N 3). The percentage of CD4-or CD8-single positive cells was 11.4% in encapsulated thymoma, 23.9% in invasive thymoma, and 77.7% in thymic cancer. The percentage of CD10-positive cells was 20.8% in encapsulated thymoma, 13.2% in invasive thymoma, and 6.0% in thymic cancer. The percentage of CD20-positive cell was 2.6% in encapsulated thymoma, 3.3% in invasive thymoma, and 31.6% in thymic cancer. There were signi®cant statistical differences in the percentages of CD4/CD8 double positive cells, CD4-or CD8-single positive cells, CD10-positive cells and CD20-positive cells among the three groups. Two cases classi®ed as invasive thymoma by pathohistological examination, however, showed the in®ltration of mature lymphocytes like as thymic cancers. Conclusions: CD41CD81 or CD101 T-lineage cells were the most reliable markers of the benignancy of thymic epithelial tumors. CD4-or CD8-single positive cells or CD20-positive cells were characteristic in thymic carcinoma. Flow cytometry on the maturity of lymphoid cells in®ltrating thymic epithelial tumors was feasible for determining their degree of malignancy. Some invasive thymomas showed the intermediate characteristics with thymomatous epithelia and mature lymphoid cells. q
Introduction
Thymoma is de®ned as a cytologically bland epithelial tumor of the thymus [1] . It exhibits a diversity of degrees of malignancy, from benign neoplasm characterized by wellencapsulated tumors, to malignant one showing direct invasion of adjacent organs, dissemination in the pleural or pericardial cavity, and lymphogenous or hematogenous metastases. Both encapsulated and invasive thymomas include lymphoid cells in varying proportions. These lymphoid cells are mostly immature T-lineage cells characterized by coexpression of CD4 and CD8, similar to normal thymocytes [2, 3] . Thymic carcinoma, which was ®rst de®ned by Levine and Rosai, is a cytologically malignant thymic epithelial tumor showing poorer clinical prognosis. The thymic carcinoma does not contain immature lymphoid cells pathohistologically [4] . The cells of thymic carcinoma are very atypical and mitotic structures are often observed. Thus thymic carcinoma has been cytologically distinguished from those of invasive thymoma. However, some con¯icts still exist in regard to distinguishing thymic carcinoma from invasive thymoma in borderline-malignant cases. Our study aimed to examine the maturation stage of lymphoid cells in®ltrating thymic epithelial tumors by¯ow cytometry, and to associate pathohistological malignancy with the¯ow cytometric ®ndings.
Materials and methods
Thymoma or thymic carcinoma tissue had been harvested from patients who underwent extended thymectomy (i.e. en bloc resection of the thymoma, thymus, and the anterior mediastinal tissue around the thymus) between 1990 and 1999. For pathohistological studies, the resected specimens were ®xed in 10% formaldehyde solution, embedded in paraf®n, sectioned, and stained with hematoxylin and eosin. Thymomas were pathohistologically examined to determine the con®guration of the neoplastic thymic epithelium (round-oval, mixed, or spindle cell type) and the degree of lymphocytic in®ltration (predominantly, moderately, or scantly lymphocytic), as described by Levine and Rosai [4] .
The thymomas were also subclassi®ed according to Masaoka's clinicopathological staging classi®cation [5] : stage I, completely encapsulated macroscopically and no capsular invasion microscopically; stage II, macroscopic invasion into surrounding fatty tissue or mediastinal pleura, or microscopic invasion of the capsule; stage III, macroscopic invasion into neighboring organs, i.e. pericardium, great vessels, or lung; stage IV, pleural or pericardial dissemination, or lymphogenous or hematogenous metastasis. Thymic carcinoma was distinguished from the thymoma based on the de®nition of Shimosato and Mukai [1] , i.e. that thymic carcinoma is malignant thymoma type II by the Levine and Rosai classi®cation [6] and several subtypes of thymic carcinoma exclusive of low grade well-differentiated thymic carcinoma as described by Kirchner and colleagues [7] . In this study, the tumors were divided into three groups:`encapsulated thymoma', i. carcinoma', characterized by diffuse growth of obviously atypical cells of an invasive nature (group C). Flow cytometry of lymphoid cells in the thymoma and the thymic carcinoma was performed as described elsewhere [8] . Brie¯y, a neoplastic part of the resected tissues was minced in phosphate-buffered saline (PBS). The suspension of the cells and PBS was ®ltered through gauze to eliminate large particles, and the lymphoid cells in the tissue were retrieved by density-gradient centrifugation. The lymphoid cells were then stained with¯uorescence-labeled monoclonal antibodies. Anti-CD3 (Leu-4, Becton Dickinson Co., CA, (BD)), anti-CD4 (Leu-3a, BD), anti-CD8 (Leu-2a, BD), anti-CD10 (CALLA, BD), anti-CD20 (Leu-16, BD), anti-CD38 (Leu-17, BD), anti-CD45RA (BD), and anti-CD45RO (BD) were used in this study to investigate Tcell differentiation. The FACScalibur system (BD) was used for three-color analysis of¯ow cytometry. Analysis of the two-or three-dimensional data was performed with CellQuest software (BD). Compensation adjustment for three-color analysis was performed before the assay with AutoCOMP software (BD). Ten thousand cells in each specimen were counted and examined by the FACScalibur system. Analysis of variance was performed to determine signi®cant differences between mean values of percent speci®c positive staining, with a P value ,0.05 denoting statistical signi®cance.
Results
Flow cytometric study was performed in 27 patients who underwent extended thymectomy between 1990 and 1998. Twenty tumors were diagnosed as thymoma. Fourteen of them were classi®ed as stage I in Masaoka's clinicopathological classi®cation, and these cases belonged to group A in this study. Four tumors were diagnosed as stage II with minimal capsular invasion, ®ve tumors as stage III, and one tumor as stage IV with lymph node metastasis. These ten tumors belonged to group B in this study. Three tumors were diagnosed as the thymic carcinoma belonged to group C in this study.
All of the patients in group A cases survived for 3 months±9 years postoperatively without tumor recurrence. Two of the group B patients died: one of perioperative acute myocardial infarction, and one of malignant lymphoma originating from the empyema cavity. One of the group C patients died of systemic metastasis of the tumor (Table 1) .
Flow cytometric ®ndings are shown in Fig. 1 and Table 2 . The proportions of CD31, CD41, CD81, CD101, CD201, CD45RA1, and CD45RO1 cells were shown in Table 2 .
Two-dimensional¯ow cytometric analysis revealed that CD4 and CD8 were co-expressed on 76.8^16.1 % of the lymphoid cells in group A, 59.2^33.7 % in group B, and 6.7^9.8% in group C. The percentage of CD4-or CD8- Fig. 1 . Two-dimensional¯ow cytometric analysis of the thymic epithelial neoplasms. Upper: a case of thymoma, stage 1 (case no. 11). Lower: a case of thymic cancer (case no. 27). Left: Dot plotted lymphoid cells by intensity of CD8 (x-axis) and CD4 (y-axis). Center: CD10 (x-axis) and CD4 (y-axis). Right: CD3 (xaxis) and CD20 (y-axis). single positive cells was 11.4^5.9% in group A, 23.9^21.9% in group B, and 77.7^4.7% in group C. There were signi®cant statistical differences in the percentages of CD10-positive cells, CD20-positive cells, CD41 CD81 cells, CD42 or CD8-single positive cells among the three groups ( Table 2 ). The percentage of CD10-positive cells was signi®cantly higher in group A than in group C. The percentage of CD20-positive cells was signi®cantly higher in group C than in groups A or B. The percentage of CD41CD81 double positive cells was signi®cantly higher in group A than in group B (P 0:011) and group C (P 0:00022). The percentage of CD4-or CD8-single positive cells was signi®cantly higher in group C than in group C (P 0:015), and 50% of the CD41CD81 double positive fraction were also CD3-positive.
Two cases in group B, however, showed characteristics very similar to those in group C. Pathohistologically they were characterized by scant lymphocytic in®ltration and mildly enlarged nucleoli without cellular atypia (Fig. 2) , nonetheless, they showed macroscopically malignant characteristics.
Discussion
In this¯ow cytometric study, percentage of CD4-and CD8-double positive cell was higher in the encapsulated thymoma group (group A, 76.8%) than in invasive thymoma group (group B, 59.2%) and thymic cancer group (group C, 6.7%). The percentage of CD4-or CD8-single positive cells was higher in group C (77.7%) than in groups A (11.4%) and B (23.9%). The percentage of CD10-positive cells was higher in group A (20.8%) than in groups B (13.2%) and C (6.0%). The percentage of CD20-positive cell was higher in group C (31.6%) than in group A (2.6%) and group B (3.3%).
Lymphoid cells in®ltrating thymoma have also been examined in an immunohistochemical study [2] and¯ow cytometric study [3] . The phenotypes of the lymphoid components in thymoma have been reported to be immature, similar to those of normal thymocytes, which mainly consist of immature T-lineage lymphoid cells. By contrast, the lymphoid cells in®ltrating thymic carcinoma have been thought to be mature lymphocytes on the basis of immunohistochemical staining [1] . Recently we reported a quantitative analysis by¯ow cytometry of the immature lymphoid cells in®ltrating thymomas. The report stated that the proportion of CD41CD81 double positive lymphoid cells in thymoma was similar to that in normal thymus tissue. CD10, which is expressed at a very low level on normal thymocytes, was expressed by 22^10% of the lymphoid cells in the thymomas, suggesting that very immature subsets of T-lymphoid cells were even present in the thymoma tissue. Thymoma has also been reported to contain immature T-lymphoid subsets expressing CD10 on their surface along with CD4 and CD38, which indicates the existence of very immature pre-T fraction in thymomas [8] .
In this study, the CD10-positive cells also expressed CD4, indicating that they were T-lineage cells. Flow cytometric analysis of the lymphoid cells in®ltrat-ing thymic epithelial neoplasms in this study showed that the degree of malignancy correlated with the maturity of the lymphoid cells in®ltrating in the tumor. That is, the proportions of CD41CD81 double-positive cells or CD101 cells in®ltrated thymic carcinoma less than invasive thymoma or encapsulated thymoma. The CD201 fraction, representing B-lineage cells, were only observed in thymic carcinoma. The percentage of B-lineage cells in the thymic carcinoma tissue was similar to that in the peripheral blood. It also supports our ®nding that the degree of malignancy in thymic epithelial neoplasm is correlated with the maturity of lymphoid cells in the tumor.
Pathologists have struggled to diagnose the grade of malignancy of thymomas since the time of Bernatz, who ®rst demonstrated that thymoma is not a type of lymphoma, but a neoplasm of the thymic epithelium [9] . Rosai and Levine [4] classi®ed thymomas by the cytological characteristics of neoplastic thymic epithelial cells among the paucity of lymphoid cells in the tumor. This classi®cation was partly successful, because thymomas with scant lymphocytic in®ltration tend to invade adjacent organs, and the postoperative outcome of thymoma patients is poorer when there is scant lymphocytic in®ltration than when lymphocytic in®ltration predominates [10] . However, the tumor classi®cation by invasiveness of Masaoka was more successful in predicting the postoperative outcome of thymoma [5] . The de®nition of thymic carcinoma is still controversial. It is generally agreed that thymic carcinoma has the extremely malignant characteristic of thymic epithelial neoplasms with vast invasiveness and systemic metastases. Rosai and Levine revised the cytological classi®cation of neoplastic thymic epithelium, highlighting cellular atypia, such as the con®guration of the nucleoli. As a result, some borderline-malignant thymic epithelial tumors have been classi®ed as`type I thymic carcinoma' [10] , or as well-differentiated thymic carcinoma of low-grade malignancy' by Mu Èller-Hermelink and colleagues [11] , or, recently, as`cortical thymoma' by Shimosato and Mukai [1] . Well-differentiated thymic carcinoma is a predominantly epithelial tumor in which the epithelial cells tend to be smaller than in cortical thymoma and possess round to oval or irregular grooved nuclei, inconspicuous nucleoli, and clear or oxyphilic cytoplasm with well-de®ned cell borders showing epidermoid features. Pallisading of epithelial cells toward the perivascular spaces and ®brous tissue is a characteristic feature. Differential diagnosis of thymic carcinoma had been reported to be possible by immunohistochemical examination. Hishima and colleagues reported that they observed CD5 expression in the cytokeratin-positive fraction of thymic carcinoma tissue. CD5 was not expressed in carcinomas of other organs, such as lung, breast, esophagus, stomach, colon, or uterine cervix [12] . Fukai and colleagues stated that a kind of anti-cytokeratin monoclonal antibody was helpful in distinguishing carcinomas of thymic origin from primary lung cancer [13] . Gilhus and colleagues performed an immunohistochemical study on thymomas focusing on expression of oncogene proteins and proliferation antigens [14] . They reported that expression of EGF-R was increased, especially in the larger thymomas, but that neither p53 nor bcl-2 was detected in the neoplastic cells. The bcl-2 staining pattern in T-lymphocytes illustrates the broad spectrum of maturational stages in thymoma lymphocytes.
The¯ow cytometric analysis was very feasible, along with conventional pathohistological study, as a means of diagnosing thymic carcinoma. It was curious that some lesions classi®ed as invasive thymomas by conventional pathohistological examination contained very mature Tlineage cells, like those in patent thymic carcinoma. This ®nding supported the`continuity theory' of thymic epithelial neoplasms, i.e. that thymic carcinoma is an extremely malignant phenotype of thymoma with invasive characteristics.
